Gouill, S. L., Wilde, V. D., Eyre, T. A., Callanan, M., Damaj, G. L., Claudel, A., Adrien, C., Houot, R., Calloch, R. L., Cacheux, V., Andre, M., Morschhauser, F., Burroni, B., Lewis, D. J., Tessoulin, B., Touzart, A. (2025). Ibrutinib, venetoclax plus CD20 monoclonal Ab: Initial results of OASIS II, a prospective randomized phase 2 trial in previously untreated mantle cell lymphoma patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7044